Molina Healthcare, Inc. (NYSE:MOH) – Analysts at Svb Leerink boosted their Q2 2019 EPS estimates for Molina Healthcare in a report released on Monday, July 15th. Svb Leerink analyst A. Gupte now expects that the company will post earnings of $2.72 per share for the quarter, up from their previous estimate of $2.58. Svb Leerink also issued estimates for Molina Healthcare’s Q4 2019 earnings at $2.58 EPS.
Molina Healthcare (NYSE:MOH) last issued its quarterly earnings results on Monday, April 29th. The company reported $3.04 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.41 by $0.63. The firm had revenue of $4.12 billion for the quarter, compared to analyst estimates of $4.07 billion. Molina Healthcare had a return on equity of 49.21% and a net margin of 4.35%. The business’s revenue was down 11.3% on a year-over-year basis. During the same period in the previous year, the company posted $1.26 earnings per share.
A number of other analysts have also issued reports on MOH. Bank of America lowered Genesee & Wyoming from a “neutral” rating to an “underperform” rating and set a $88.65 price target on the stock. in a research note on Tuesday, April 30th. Barclays set a $145.00 price objective on Sanderson Farms and gave the stock a “hold” rating in a research note on Friday, May 31st. Morgan Stanley set a $207.00 price objective on Alibaba Group and gave the stock a “buy” rating in a research note on Friday, July 12th. Wells Fargo & Co set a $12.00 price objective on Infosys and gave the stock a “hold” rating in a research note on Friday, May 31st. Finally, BMO Capital Markets set a C$106.00 price objective on FirstService and gave the stock a “market perform” rating in a research note on Monday, June 3rd. One analyst has rated the stock with a sell rating, six have assigned a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Molina Healthcare has an average rating of “Buy” and a consensus target price of $160.25.
Shares of NYSE:MOH opened at $142.09 on Wednesday. The company has a debt-to-equity ratio of 0.74, a current ratio of 1.57 and a quick ratio of 1.57. The stock has a 50 day moving average price of $145.28. The firm has a market capitalization of $8.74 billion, a price-to-earnings ratio of 12.82, a PEG ratio of 0.98 and a beta of 1.28. Molina Healthcare has a 1 year low of $101.87 and a 1 year high of $159.00.
Institutional investors have recently made changes to their positions in the company. PNC Financial Services Group Inc. increased its position in Molina Healthcare by 18.1% during the 4th quarter. PNC Financial Services Group Inc. now owns 3,748 shares of the company’s stock valued at $436,000 after purchasing an additional 575 shares during the period. Raymond James & Associates increased its position in Molina Healthcare by 276.4% during the 4th quarter. Raymond James & Associates now owns 14,974 shares of the company’s stock valued at $1,740,000 after purchasing an additional 10,996 shares during the period. Raymond James Financial Services Advisors Inc. purchased a new position in Molina Healthcare during the 4th quarter valued at $369,000. Advisor Group Inc. increased its position in Molina Healthcare by 44.9% during the 4th quarter. Advisor Group Inc. now owns 3,305 shares of the company’s stock valued at $383,000 after purchasing an additional 1,024 shares during the period. Finally, GSA Capital Partners LLP purchased a new position in Molina Healthcare during the 4th quarter valued at $301,000. 99.90% of the stock is currently owned by institutional investors and hedge funds.
In other Molina Healthcare news, Director Daniel Cooperman sold 4,004 shares of the business’s stock in a transaction on Thursday, June 6th. The stock was sold at an average price of $155.00, for a total transaction of $620,620.00. Following the transaction, the director now owns 4,096 shares of the company’s stock, valued at $634,880. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Garrey Carruthers sold 1,300 shares of the business’s stock in a transaction on Monday, June 10th. The stock was sold at an average price of $152.75, for a total value of $198,575.00. The disclosure for this sale can be found here. Insiders have sold 6,304 shares of company stock worth $945,495 in the last three months. 0.77% of the stock is currently owned by corporate insiders.
About Molina Healthcare
Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.
Featured Article: Why is momentum important to successful trading?
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.